Stellbrink, H., & Hoffmann, C. (2018). Cabotegravir: Its potential for antiretroviral therapy and preexposure prophylaxis. Current opinion in HIV & AIDS, 13(4), 334. https://doi.org/10.1097/COH.0000000000000480
Chicago Style (17th ed.) CitationStellbrink, Hans-Jürgen, and Christian Hoffmann. "Cabotegravir: Its Potential for Antiretroviral Therapy and Preexposure Prophylaxis." Current Opinion in HIV & AIDS 13, no. 4 (2018): 334. https://doi.org/10.1097/COH.0000000000000480.
MLA (9th ed.) CitationStellbrink, Hans-Jürgen, and Christian Hoffmann. "Cabotegravir: Its Potential for Antiretroviral Therapy and Preexposure Prophylaxis." Current Opinion in HIV & AIDS, vol. 13, no. 4, 2018, p. 334, https://doi.org/10.1097/COH.0000000000000480.
Warning: These citations may not always be 100% accurate.